{"Title": "Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: A cross-sectional analysis of baseline data", "Year": 2015, "Source": "Lancet Neurol.", "Volume": "14", "Issue": 2, "Art.No": null, "PageStart": 174, "PageEnd": 182, "CitedBy": 82, "DOI": "10.1016/S1474-4422(14)70321-7", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922628562&origin=inward", "Abstract": "\u00a9 2015 Elsevier Ltd.Background: Friedreich's ataxia is a rare autosomal recessive neurodegenerative disorder. Here we report cross-sectional baseline data to establish the biological and clinical characteristics for a prospective, international, European Friedreich's ataxia database registry. Methods: Within the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) framework, we assessed a cohort of patients with genetically confirmed Friedreich's ataxia. The primary outcome measure was the Scale for the Assessment and Rating of Ataxia (SARA) and secondary outcome measures were the Inventory of Non-Ataxia Signs (INAS), the performance-based coordination test Spinocerebellar Ataxia Functional Index (SCAFI), the neurocognitive phonemic verbal fluency test, and two quality-of-life measures: the activities of daily living (ADL) part of the Friedreich's Ataxia Rating Scale and EQ-5D. The Friedreich's ataxia cohort was subdivided into three groups: early disease onset (\u226414 years), intermediate onset (15-24 years), and late onset (\u226525 years), which were compared for clinical characteristics and outcome measures. We used linear regression analysis to estimate the annual decline of clinical outcome measures based on disease duration. This study is registered with ClinicalTrials.gov, number NCT02069509. Findings: We enrolled 592 patients with genetically confirmed Friedreich's ataxia between Sept 15, 2010, and April 30, 2013, at 11 sites in seven European countries. Age of disease onset was inversely correlated with the number of GAA repeats in the frataxin (. FXN) gene: every 100 GAA repeats on the smaller repeat allele was associated with a 2\u00b73 year (SE 0\u00b72) earlier onset. Regression analyses showed significant estimated annual worsening of SARA (regression coefficient 0\u00b786 points [SE 0\u00b705], INAS (0\u00b714 points [0\u00b701]), SCAFI Z scores (-0\u00b709 [0\u00b701]), verbal fluency (-0\u00b734 words [0\u00b707]), and ADL (0\u00b764 points [0\u00b704]) during the first 25 years of disease; the regression slope for health-related quality-of-life state from EQ-5D was not significant (-0\u00b733 points [0\u00b718]). For SARA, the predicted annual rate of worsening was significantly higher in early-onset patients (n=354; 1\u00b704 points [0\u00b713]) and intermediate-onset patients (n=137; 1\u00b717 points [0\u00b722]) than in late-onset patients (n=100; 0\u00b756 points [0\u00b710]). Interpretation: The results of this cross-sectional baseline analysis of the EFACTS cohort suggest that earlier disease onset is associated with larger numbers of GAA repeats and more rapid disease progression. The differential estimated progression of ataxia symptoms related to age of onset have implications for the design of clinical trials in Friedreich's ataxia, for which SARA might be the most suitable measure to monitor disease progression. Funding: European Commission.", "AuthorKeywords": null, "IndexKeywords": ["Activities of Daily Living", "Adolescent", "Adult", "Aged", "Child", "Cohort Studies", "Cross-Sectional Studies", "Databases, Factual", "Europe", "Female", "Friedreich Ataxia", "Humans", "Longitudinal Studies", "Male", "Middle Aged", "Prospective Studies", "Translational Medical Research", "Trinucleotide Repeats", "Young Adult"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84922628562", "SubjectAreas": [["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"24451065800": {"Name": "Reetz K.", "AuthorID": "24451065800", "AffiliationID": "60007774", "AffiliationName": "Institute of Neuroscience and Medicine 4, Research Centre J\u00fclich"}, "55292692000": {"Name": "Dogan I.", "AuthorID": "55292692000", "AffiliationID": "60007774", "AffiliationName": "Institute of Neuroscience and Medicine 4, Research Centre J\u00fclich"}, "55311625400": {"Name": "Costa A.S.", "AuthorID": "55311625400", "AffiliationID": "110546621", "AffiliationName": "JARA-Translational Brain Medicine"}, "15761737300": {"Name": "Dafotakis M.", "AuthorID": "15761737300", "AffiliationID": "60016653, 60001097", "AffiliationName": "Department of Neurology, University Hospital Rheinisch-Westf\u00e4lische Technische Hochschule RWTH, Aachen"}, "55502681300": {"Name": "Fedosov K.", "AuthorID": "55502681300", "AffiliationID": "60016653, 60001097", "AffiliationName": "Department of Neurology, University Hospital Rheinisch-Westf\u00e4lische Technische Hochschule RWTH, Aachen"}, "7201479829": {"Name": "Schulz J.B.", "AuthorID": "7201479829", "AffiliationID": "110546621", "AffiliationName": "JARA-Translational Brain Medicine"}, "6603845190": {"Name": "Giunti P.", "AuthorID": "6603845190", "AffiliationID": "60019953", "AffiliationName": "Department of Molecular Neuroscience, UCL Institute of Neurology"}, "55443104800": {"Name": "Parkinson M.H.", "AuthorID": "55443104800", "AffiliationID": "60019953", "AffiliationName": "Department of Molecular Neuroscience, UCL Institute of Neurology"}, "7201380026": {"Name": "Sweeney M.G.", "AuthorID": "7201380026", "AffiliationID": "60020736", "AffiliationName": "Neurogenetics Unit, National Hospital for Neurology and Neurosurgery"}, "7005081882": {"Name": "Mariotti C.", "AuthorID": "7005081882", "AffiliationID": "60017275, 60006583", "AffiliationName": "Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Neurologico Carlo Besta"}, "55969644600": {"Name": "Panzeri M.", "AuthorID": "55969644600", "AffiliationID": "60017275, 60006583", "AffiliationName": "Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Neurologico Carlo Besta"}, "28767969000": {"Name": "Nanetti L.", "AuthorID": "28767969000", "AffiliationID": "60017275, 60006583", "AffiliationName": "Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Neurologico Carlo Besta"}, "56073393300": {"Name": "Arpa J.", "AuthorID": "56073393300", "AffiliationID": "60028162, 60105312", "AffiliationName": "Reference Unit of Hereditary Ataxias and Paraplegias, Department of Neurology, Instituto de Investigaci\u00f3n Sanitaria, Hospital Universitario La Paz"}, "16064232000": {"Name": "Sanz-Gallego I.", "AuthorID": "16064232000", "AffiliationID": "60028162, 60105312", "AffiliationName": "Reference Unit of Hereditary Ataxias and Paraplegias, Department of Neurology, Instituto de Investigaci\u00f3n Sanitaria, Hospital Universitario La Paz"}, "24741153500": {"Name": "Durr A.", "AuthorID": "24741153500", "AffiliationID": "60120341, 60008134, 60000905, 60001422", "AffiliationName": "Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1127, Centre National de la Recherche Scientifique Unit\u00e9 mixte recherch\u00e9, 7225"}, "7102873964": {"Name": "Charles P.", "AuthorID": "7102873964", "AffiliationID": "60120341, 60008134, 60000905, 60001422", "AffiliationName": "Institut du Cerveau et de la Moelle \u00e9pini\u00e8re, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1127, Centre National de la Recherche Scientifique Unit\u00e9 mixte recherch\u00e9, 7225"}, "6701515786": {"Name": "Boesch S.", "AuthorID": "6701515786", "AffiliationID": "60008222", "AffiliationName": "Department of Neurology, Medical University Innsbruck"}, "36151164400": {"Name": "Nachbauer W.", "AuthorID": "36151164400", "AffiliationID": "60008222", "AffiliationName": "Department of Neurology, Medical University Innsbruck"}, "6603746477": {"Name": "Klopstock T.", "AuthorID": "6603746477", "AffiliationID": "60103674", "AffiliationName": "German Center for Neurodegenerative Diseases (DZNE)"}, "55444705000": {"Name": "Karin I.", "AuthorID": "55444705000", "AffiliationID": "60000291, 60028717", "AffiliationName": "Friedrich-Baur-Institute, Department of Neurology, University of Munich"}, "6506263121": {"Name": "Depondt C.", "AuthorID": "6506263121", "AffiliationID": "60000145", "AffiliationName": "Laboratory of Experimental Neurology, Universit\u00e9 Libre de Bruxelles"}, "7005806146": {"Name": "Pandolfo M.", "AuthorID": "7005806146", "AffiliationID": "60000145", "AffiliationName": "Laboratory of Experimental Neurology, Universit\u00e9 Libre de Bruxelles"}, "55215021300": {"Name": "vom Hagen J.M.", "AuthorID": "55215021300", "AffiliationID": "60103674", "AffiliationName": "German Center for Neurodegenerative Diseases (DZNE)"}, "7005610155": {"Name": "Sch\u00f6ls L.", "AuthorID": "7005610155", "AffiliationID": "60103674", "AffiliationName": "German Center for Neurodegenerative Diseases (DZNE)"}, "36860404000": {"Name": "Giordano I.A.", "AuthorID": "36860404000", "AffiliationID": "60103674", "AffiliationName": "German Center for Neurodegenerative Diseases (DZNE)"}, "26643063400": {"Name": "Klockgether T.", "AuthorID": "26643063400", "AffiliationID": "60103674", "AffiliationName": "German Center for Neurodegenerative Diseases (DZNE)"}, "56268118800": {"Name": "B\u00fcrk K.", "AuthorID": "56268118800", "AffiliationID": "60012556", "AffiliationName": "Department of Neurology, Philipps University of Marburg"}}}